Schwarz Pharma Manufacturing, Inc. - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Schwarz Pharma Manufacturing, Inc.

Pharmaceutical Technology

Corporate description



At Schwarz Pharma, Inc., we have the facility; the equipment; the professional, experienced staff; and the commitment to be your full-service contract manufacturer. Our services include all phases of manufacturing, from product development to the distribution of your product. You select the services you require.

Schwarz Pharma achieves excellence via investment in people, systems, and procedures, process optimization, and infrastructure. We can assure you a well-trained team, modern facilities, and product quality that meet your specifications.

You can place your product here with confidence.

Technical services

Solid-dose manufacturing

Facilities

Over 250,000 ft2 of manufacturing facilities located in Seymour, Indiana.

Markets served

Multinational market presence.












Schwarz Pharma Manufacturing, Inc.

1101 "C" Ave. West
Seymour, IN 47274

TELEPHONE
812.523.5490

FAX
812.523.1887

NUMBER OF EMPLOYEES
350 US
4000 worldwide

DATE FOUNDED
1946

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
New Congress to Tackle Health Reform, Biomedical Innovation, Tax Policy
Combination Products Challenge Biopharma Manufacturers
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality
Source: Pharmaceutical Technology,
Click here